Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 22, 2011

Indian supreme court slams drug prices

The Supreme Court of India has informed the country's central government that drug prices are too high and should not be raised again.

By Liam Stoker

The Supreme Court of India has informed the country’s central government that drug prices are too high and should not be raised again.

The criticism came during a Public Interest Litigation hearing, discussing the government’s newly proposed National Pharmaceuticals Pricing Policy.

The policy hopes to separate drug ceiling prices from bulk manufacturing costs, a move which critics claim would see the prices of essential drugs increase beyond the means of many people.

India’s Department of Chemicals and Petrochemicals confirmed that under the new policy, all 348 medicines on the country’s National List of Essential Medicines would come under price control instead of the 74 bulk drugs currently controlled.

The hearing was adjourned until 17 January 2012.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU